Citigroup Forecasts Strong Price Appreciation for Docusign (NASDAQ:DOCU) Stock

Docusign (NASDAQ:DOCU) had its price target upped by stock analysts at Citigroup from $110.00 to $115.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Citigroup’s price target would suggest a potential upside of 44.00% from the company’s current price.

A number of other research analysts have also recently issued reports on DOCU. Morgan Stanley cut their target price on shares of Docusign from $92.00 to $86.00 and set an “equal weight” rating for the company in a research note on Friday, June 6th. Wall Street Zen cut shares of Docusign from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. Wedbush lowered their target price on shares of Docusign from $100.00 to $85.00 and set a “neutral” rating for the company in a report on Thursday, June 12th. JMP Securities reaffirmed a “market outperform” rating and set a $124.00 target price on shares of Docusign in a report on Tuesday, June 3rd. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Docusign in a report on Friday, June 6th. Four investment analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company. Based on data from MarketBeat.com, Docusign currently has a consensus rating of “Hold” and an average price target of $93.14.

Docusign Trading Up 4.7%

NASDAQ:DOCU opened at $79.86 on Thursday. Docusign has a 1 year low of $54.31 and a 1 year high of $107.86. The firm has a 50 day moving average of $75.53 and a 200-day moving average of $79.40. The stock has a market capitalization of $16.14 billion, a P/E ratio of 60.05, a price-to-earnings-growth ratio of 28.46 and a beta of 1.02.

Docusign (NASDAQ:DOCU) last posted its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.84 by $0.08. Docusign had a net margin of 9.08% and a return on equity of 13.98%. The company had revenue of $800.64 million during the quarter, compared to analysts’ expectations of $780.35 million. During the same quarter in the previous year, the company posted $0.97 earnings per share. Docusign’s quarterly revenue was up 8.8% compared to the same quarter last year. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, analysts forecast that Docusign will post 1.17 EPS for the current fiscal year.

Docusign declared that its Board of Directors has initiated a stock repurchase plan on Thursday, June 5th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to buy up to 6.6% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s leadership believes its shares are undervalued.

Insider Activity

In other news, CEO Allan C. Thygesen sold 40,000 shares of the business’s stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $77.51, for a total value of $3,100,400.00. Following the completion of the transaction, the chief executive officer owned 143,983 shares of the company’s stock, valued at $11,160,122.33. The trade was a 21.74% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Robert Chatwani sold 22,875 shares of the business’s stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $74.79, for a total transaction of $1,710,821.25. Following the completion of the transaction, the insider directly owned 72,126 shares of the company’s stock, valued at $5,394,303.54. This trade represents a 24.08% decrease in their position. The disclosure for this sale can be found here. Insiders sold 78,552 shares of company stock worth $5,983,631 over the last quarter. Corporate insiders own 1.01% of the company’s stock.

Hedge Funds Weigh In On Docusign

Several institutional investors and hedge funds have recently made changes to their positions in the company. Palogic Value Management L.P. lifted its position in Docusign by 2.2% in the 1st quarter. Palogic Value Management L.P. now owns 5,438 shares of the company’s stock valued at $443,000 after acquiring an additional 117 shares in the last quarter. Wealthspire Advisors LLC lifted its position in Docusign by 1.9% in the 1st quarter. Wealthspire Advisors LLC now owns 6,579 shares of the company’s stock valued at $536,000 after acquiring an additional 122 shares in the last quarter. Foundry Partners LLC lifted its position in Docusign by 1.5% in the 1st quarter. Foundry Partners LLC now owns 8,491 shares of the company’s stock valued at $691,000 after acquiring an additional 125 shares in the last quarter. Bessemer Group Inc. lifted its position in Docusign by 27.5% in the 1st quarter. Bessemer Group Inc. now owns 602 shares of the company’s stock valued at $49,000 after acquiring an additional 130 shares in the last quarter. Finally, Centaurus Financial Inc. lifted its position in Docusign by 2.6% in the 2nd quarter. Centaurus Financial Inc. now owns 5,398 shares of the company’s stock valued at $420,000 after acquiring an additional 136 shares in the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.